Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of VI-0521 (Qsymia) on Ambulatory Blood Pressure in Overweight or Obese Subjects
NCT05215418Phase 4Completed
- Sponsor
- VIVUS
- Start
- Jan 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of phentermine + topiramate in obesity, Overweight, sponsored by VIVUS. Started Jan 2022; status: completed.
02
Drugs
phentermine + topiramate
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT05215418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05215418.